Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

High debt masks Marstons value

Babcock International restructuring benefits

AIM movers: Brand Architekts cutting losses and ex-dividends

Argo Blockchain raises cash to reduce debt

AIM movers: OptiBiotix Health soars on SweetBiotix news and Watkin Jones warning

EY confirms Darktrace accounts

AIM movers: Arbuthnot Banking interest boost and CleanTech Lithium rally continues

Resource increase at Ariana Resources project in Kosovo

AIM movers: Gresham House takeover and Dianomi hit by lack of online readership

Critical metals investment opportunities: Two London listed shares

Aquis weekly movers: Increased trading in KR1 shares

AIM weekly movers: Helium One Global obtains rig

Consumer switching boosts McBride

AIM movers: Ilika rebounds and Zoo Digital hit by Hollywood strikes

Powering up production without draining the batteries

Predator Oil & Gas discovers potential gas reservoir in Morocco

AIM movers: Corero Network Security grows revenues and musicMagpie invests in rental assets

AIM movers: Eqtec sells French project and Fiinu fails to raise bank funding

Positive sampling results for Great Southern Copper

AIM movers: Potential STM bid and Angus Energy negotiating bridge facility

DWF bid approach

AIM movers: Helium One buys drilling rig and Totally warns of tough conditions

Is it time to buy Currys?

Aquis weekly movers: S-Ventures moving towards profitability

AIM weekly movers: Yourgene Health takeover

Potential new lithium project investment

Former Alterian boss reversing business into quoted shell

AIM movers: Aptamer contracts and Quadrise cash call hits share price

Lok’nStore offer to shareholders

YouGov buying GfK consumer panel business

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020